Compound Summary
4-aminopyridine
Compound Information
4-aminopyridine
Compound Name: | 4-aminopyridine |
Compound CID: | 1727 |
Synonyms: | 4-aminopyridine 504-24-5 pyridin-4-amine 4-Pyridinamine Fampridine More... |
Iupac Name: | pyridin-4-amine |
InChI: | InChI=1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7) |
InChIKey: | NUKYPUAOHBNCPY-UHFFFAOYSA-N |
Canonical Smiles: | C1=CN=CC=C1N |
Isomeric Smiles: | C1=CN=CC=C1N |
Molecular Weight: | 94.11 |
Molecular Formula: | C5H6N2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
4-aminopyridine
Molecular Weight: | 94.11 |
Molecular Formula: | C5H6N2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 7 |
Complexity: | 48 |
Synonyms
4-aminopyridine
| 4-aminopyridine | 4-aminopyridine |
|---|---|
4-aminopyridine |
504-24-5 |
pyridin-4-amine |
4-Pyridinamine |
Fampridine |
Dalfampridine |
4-Pyridylamine |
p-Aminopyridine |
Avitrol |
4-AP |
gamma-Aminopyridine |
Ampyra |
Avitrol 200 |
Pyridine, 4-amino- |
Amino-4 pyridine |
Pimadin (free base) |
Compound 1861 |
Phillips 1861 |
FAMPYRA |
Neurelan |
Amaya |
Prc 1237 |
VMI 10-3 |
C5H6N2 |
4-amino pyridine |
4-amino-pyridine |
UNII-BH3B64OKL9 |
4- Aminopyridine |
pyridin-4-ylamine |
EL-970 |
NSC 15041 |
.gamma.-Aminopyridine |
4-AMINOPYRDINE |
N07XX07 |
BH3B64OKL9 |
MLS000069400 |
CHEMBL284348 |
Dalfampridine (4-aminopyridine) |
CHEBI:34385 |
MFCD00006439 |
NSC-15041 |
4-Pyridinamine, labeled with deuterium |
NCGC00015009-08 |
SMR000058211 |
4 Aminopyridine |
Fampridine-SR |
DSSTox_CID_3870 |
DSSTox_RID_77212 |
DSSTox_GSID_23870 |
4AP |
Caswell No. 038 |
VMI-103 |
Mi-W-3 |
916979-36-7 |
CAS-504-24-5 |
Ampyra (TN) |
HSDB 6037 |
VMI 103 |
SR-01000075299 |
EINECS 207-987-9 |
RCRA waste no. P008 |
EPA Pesticide Chemical Code 069201 |
Dalfampridine USAN:INN |
BRN 0105782 |
fampridina |
fampridinum |
Frampridine |
Ampydin |
BIIB041 |
Pymadin |
AI3-52547 |
BIIB 041 |
Fampridine-PR |
Dalfampridine-ER |
4-pyridyl amine |
para-aminopyridine |
pyridine-4-amine |
3rxf |
Neurelan (TN) |
pyridine-4-ylamine |
Fampridine INN |
Fampyra (TN) |
pyridin-4-yl-amine |
4-Aminopyridine 10 |
Philips 1861 |
Dalfampridine (USAN) |
Spectrum_000155 |
Tocris-0940 |
Fampridine (JAN/INN) |
4-Aminopyridine, 98% |
PYRIDINE,4-AMINO |
Opera_ID_1768 |
Spectrum2_001413 |
Spectrum3_000914 |
Spectrum4_001013 |
Spectrum5_001501 |
Lopac-A-0152 |
UPCMLD-DP125 |
WLN: T6NJ DZ |
4-Aminopyridine (4-AP) |
4-Aminopyridine, >=99% |
1,4-dihydropyridin-4-imine |
Lopac0_000032 |
BSPBio_001562 |
KBioGR_000282 |
KBioGR_001505 |
KBioSS_000282 |
KBioSS_000635 |
4-imino-1,4-dihydropyridine |
5-22-09-00106 (Beilstein Handbook Reference) |
ARONIS25052 |
DivK1c_000572 |
SPECTRUM1501130 |
SPBio_001486 |
4 AP |
BIIB-041 |
GTPL2416 |
CL-COB-III-274-1 |
DTXSID0023870 |
UPCMLD-DP125:001 |
AMPD00207 |
BDBM10458 |
HMS501M14 |
KBio1_000572 |
KBio2_000282 |
KBio2_000635 |
KBio2_002850 |
KBio2_003203 |
KBio2_005418 |
KBio2_005771 |
KBio3_000563 |
KBio3_000564 |
KBio3_001888 |
NINDS_000572 |
Bio1_000353 |
Bio1_000842 |
Bio1_001331 |
Bio2_000282 |
Bio2_000762 |
HMS1361O04 |
HMS1791O04 |
HMS1921H15 |
HMS1989O04 |
HMS2092F05 |
HMS2234N24 |
HMS3260G05 |
HMS3267E21 |
HMS3370J03 |
HMS3402O04 |
HMS3414H15 |
HMS3678H13 |
HMS3886I09 |
KUC111877N |
Pharmakon1600-01501130 |
ZINC599985 |
ACT05167 |
HY-B0604 |
NSC15041 |
VMI-10-3 |
Tox21_110065 |
Tox21_200793 |
Tox21_500032 |
BBL009925 |
CCG-39031 |
HTS004685 |
NSC757845 |
RB8003 |
s5028 |
SBB004393 |
STK298717 |
AKOS000119896 |
Tox21_110065_1 |
BS-3729 |
DB06637 |
LP00032 |
LS20499 |
MCULE-6604546217 |
NSC-757845 |
QC-4324 |
SDCCGMLS-0066228.P001 |
SDCCGSBI-0050021.P004 |
VP10051 |
IDI1_000572 |
IDI1_034032 |
p-Aminopyridine UN2671 Poison |
NCGC00015009-01 |
NCGC00015009-02 |
NCGC00015009-03 |
NCGC00015009-04 |
NCGC00015009-05 |
NCGC00015009-06 |
NCGC00015009-07 |
NCGC00015009-09 |
NCGC00015009-10 |
NCGC00015009-11 |
NCGC00015009-12 |
NCGC00015009-13 |
NCGC00015009-14 |
NCGC00015009-16 |
NCGC00015009-23 |
NCGC00015009-24 |
NCGC00024890-01 |
NCGC00024890-02 |
NCGC00024890-03 |
NCGC00024890-04 |
NCGC00024890-05 |
NCGC00024890-06 |
NCGC00024890-07 |
NCGC00024890-08 |
NCGC00024890-09 |
NCGC00024890-10 |
NCGC00258347-01 |
NCGC00260717-01 |
BP-21343 |
SBI-0050021.P003 |
DB-028705 |
A0414 |
AM20061261 |
B3530 |
EU-0100032 |
FT-0665455 |
ST45053817 |
AZ0001-0464 |
A 0152 |
D04127 |
68146-EP2269990A1 |
68146-EP2284157A1 |
68146-EP2289894A2 |
68146-EP2298731A1 |
68146-EP2308874A1 |
68146-EP2380872A1 |
79676-EP2305695A2 |
79676-EP2305696A2 |
79676-EP2305697A2 |
79676-EP2305698A2 |
AB00052209_12 |
J.Pharmacol.Exp.Ther. 275:864 (1995) |
AC-907/25014071 |
Q372539 |
4-Aminopyridine, PESTANAL(R), analytical standard |
Q-200436 |
SR-01000075299-1 |
SR-01000075299-3 |
SR-01000075299-5 |
F2190-0487 |
Z955123498 |
METHYL3,5-DIBROMO-2,4-DIHYDROXY-6-METHYLBENZOATE |
Dalfampridine, United States Pharmacopeia (USP) Reference Standard |
Experimental Data
4-aminopyridine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 8.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
4-aminopyridine
Statistics Data
4-aminopyridine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 8.000000000000000 | 1 | 1 |
Statistics Data Visualization
4-aminopyridine
